Jamal Musiala’s Neurological Condition: What It Means for Bayern Munich and Modern Player Health Management
Jamal Musiala collapsed twice during pre-season friendlies. The first happened against RB Leipzig. The second occurred days later against 1. FC Heidenheim. Each time the 23-year-old Bayern Munich star went down on the pitch, the football world held its breath.
Musiala later revealed he suffers from a neurological dysfunction. The condition causes brief episodes of unconsciousness known as absence seizures. According to multiple German outlets, including Bild and kicker, the problem was already known to the club last season. At that time medication kept it under control. No collapses occurred for months. Then, during the summer of 2026, Musiala adjusted his dosage. The change triggered a reaction. The result was two frightening on-field incidents.
Bayern’s response has been cautious. Musiala was ruled out of the DFL-Supercup in Dortmund, which Bayern won 2-1 without him. He also missed the Bundesliga opener against VfB Stuttgart on August 29. Coach Vincent Kompany said he is “totally calm” about the situation. Bayern’s medical staff have switched Musiala back to the medication that worked before. Bild reported that it typically takes ten to fourteen days for a new dose to stabilize. The plan is to reintroduce Musiala to full team training gradually. He might return for the second matchday at Schalke.
What exactly is a neurological dysfunction in this context? A neurologist consulted by Bild described the episodes as likely epileptic seizures. That does not mean Musiala cannot play top-level football. With proper medication, many athletes with epilepsy lead normal careers. The key is finding the right drug and dose, and sticking with it. Musiala’s doctors have explicitly advised him to continue playing. They consider him physically healthy, Sport1 reported. The issue is strictly related to the temporary imbalance caused by the medication change.
Bayern’s handling of the situation shows how modern clubs manage sensitive health issues. Sporting director Max Eberl confirmed the club knew about the condition for over a year. They chose not to disclose it because there were no symptoms. Once the collapses occurred, they communicated clearly and let the player speak first. Musiala posted about his condition on Instagram, owning the narrative. The club backed him by prioritizing his health over competitive urgency. Even with the Supercup and Bundesliga opener at stake, Bayern gave Musiala time.
The absence has opened a door for others. Nathaniel Brown, a summer signing, filled the number ten role in the Supercup and scored. He is expected to start against Stuttgart. Serge Gnabry remains out with a long-term adductor injury. Konrad Laimer returned from a muscle issue and played the full Supercup. The squad has depth, but no one replaces Musiala’s dribbling and creativity. Bayern will need to adapt without him for at least one more match.
Why does this matter beyond Bayern? Musiala’s case highlights a broader challenge in elite sport. Athletes are under constant pressure to perform. Medication adjustments, even small ones, can have serious side effects. Clubs must balance the desire to field their best players with the duty to protect long-term health. Bayern’s approach—calm, methodical, player-first—sets a standard. The message is clear: football can wait. Health cannot.